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The chlorovirus Paramecium bursaria chlorella virus 1
(PBCV-1) is a large dsDNA virus that infects the microalga Chlo-
rella variabilis NC64A. Unlike most other viruses, PBCV-1
encodes most, if not all, of the machinery required to glycosylate
its major capsid protein (MCP). The structures of the four
N-linked glycans from the PBCV-1 MCP consist of nonasaccha-
rides, and similar glycans are not found elsewhere in the three
domains of life. Here, we identified the roles of three virus-en-
coded glycosyltransferases (GTs) that have four distinct GT
activities in glycan synthesis. Two of the three GTs were previ-
ously annotated as GTs, but the third GT was identified in this
study. We determined the GT functions by comparing the WT
glycan structures from PBCV-1 with those from a set of PBCV-1
spontaneous GT gene mutants resulting in antigenic variants
having truncated glycan structures. According to our working
model, the virus gene a064r encodes a GT with three domains:
domain 1 has a -L-rhamnosyltransferase activity, domain 2 has
an -L-rhamnosyltransferase activity, and domain 3 is a methyl-
transferase that decorates two positions in the terminal -L-rh-
amnose (Rha) unit. The a075l gene encodes a -xylosyltrans-
ferase that attaches the distal D-xylose (Xyl) unit to the L-fucose
(Fuc) that is part of the conserved N-glycan core region. Last,
gene a071r encodes a GT that is involved in the attachment of a
semiconserved element, -D-Rha, to the same L-Fuc in the core
region. Our results uncover GT activities that assemble four of
the nine residues of the PBCV-1 MCP N-glycans.
Structural proteins of many viruses, such as rhabdoviruses, her-
pesviruses, poxviruses, and paramyxoviruses, are glycosylated.
Most virus glycoproteins are N-linked to Asn via N-acetylgluco-
samine (GlcNAc), whereas less frequent O-linked glycosylation
also occurs (1). The majority of the viruses studied to date use
host-encoded glycosyltransferases (GTs)3 and glycosidases
located in the endoplasmic reticulum and Golgi apparatus to add
and remove N-linked sugar residues from virus glycoproteins
either co-translationally or shortly after translation of the protein
(2–6). Post-translational glycosylation can aid in protein folding,
protein stability, progression in the secretory pathway, and host–
virus interactions.
One group of viruses that differs from the above scenario is
the plaque-forming Chloroviruses (family Phycodnaviridae)
that infect certain isolates of chlorella-like green algae (7). The
viruses are divided into four groups, depending on the algal host
infected: chloroviruses that infect Chlorella variabilis NC64A
are referred to as NC64A viruses, those that infect C. variabilis
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Syngen 2-3 are referred to as Osy viruses, those that infect Chlo-
rella heliozoae SAG 3.83 are referred to as SAG viruses, and
those that infect Micractinium conductrix Pbi are referred to as
Pbi viruses. The prototype chlorovirus Paramecium bursaria
chlorella virus (PBCV-1) is an NC64A virus (8), and its 330-kb
genome is predicted to encode 416 proteins (9). The major cap-
sid protein (MCP or Vp54) is coded by the gene a430l, and its
gene product has a predicted molecular mass of 48,165 Da,
which increases to 53,790 Da due to N-glycosylation at four
positions (10, 11).
The predominant glycoform of the four PBCV-1 N-glycans is
a nonasaccharide (Fig. 1, WT) (11) with several unusual struc-
tural features, including the following: (i) it is not linked to the
typical Asn-X-(Thr/Ser) sequon; (ii) it is highly branched; (iii)
-glucose (Glc) forms the N-linkage with Asn; (iv) fucose (Fuc)
is substituted at all available positions; and (v) there are two
rhamnose (Rha) residues with opposite configurations plus an
L-Rha capped with two O-methyl groups. Two monosaccha-
rides, arabinose (Ara) and mannose (Man), occur as nonstoi-
chiometric substituents, resulting in the existence of four gly-
coforms (Fig. 1). Currently, structures of this type are unknown
elsewhere in the three domains of life.
The discovery of these glycans has prompted our interest in
viral glyco-related genes. In this regard, 17 of the PBCV-1 genes
encode enzymes that manipulate sugars at different levels (12),
with six of them annotated as encoding putative GTs: a064r
(638 amino acids), a111/114r (860 aa), a219/222/226r (677 aa),
a473l (517 aa), a546l (396 aa), and a075l (280 aa) (Table S1). In
addition, a098r encodes a functional hyaluronate synthase (13).
The genes encoding these GTs are scattered throughout the
genome of the virus, and PSORT predicted that most of these
proteins are soluble and located in the cytoplasm; a473l and
a219/222/226r are predicted to encode GTs with six and nine
transmembrane domains, respectively, whereas the ngLOC
program predicts that A075L is located in the chloroplast, but
only at a 15% confidence level.
Thus, PBCV-1 encodes six GTs, a small number when
compared with the complexity of its N-glycans. One solution
to this paradox is that one or more of the six GTs might have
multiple functional domains, making this restricted reper-
toire of enzymes sufficient to synthesize these structures. A
second possibility is that some other virus genes encode
enzymes that do not match GTs in the databases and so are
overlooked during the searches. Finally, we cannot exclude
the possibility that a host-encoded GT(s) could be involved
in the glycosylation process.
The protein encoded by gene a064r is of special interest. This
protein is coded by PBCV-1 but not by any other chlorovirus
where the glycan structure is known (12), suggesting that the
a064r gene product is involved in the synthesis of a structural
motif of the N-glycan not shared with the other chloroviruses
(14 –16). In addition, several spontaneous mutants (or anti-
genic variants) in a064r have been isolated, and their MCPs
migrate faster on SDS-PAGE compared with the MCP of
PBCV-1, suggesting that the glycan portion of the capsid pro-
tein is altered.
These PBCV-1 spontaneous mutants are divided into six
antigenic classes, each denoted with a letter, based on their
differential reaction to five different polyclonal antibodies (12,
17). Each class reacts specifically with one polyclonal antibody
preparation, except for Class E, which cross-reacts with Class A
and B polyclonal antibodies, suggesting that the phenotype of
Class E variants shares some of the structural features of the
other two variants. Notably, all six antigenic classes, except for
C, have a mutation in the a064r gene (Table 1 and Fig. 1).
For the reasons cited above and elsewhere (12, 18), we
hypothesize that the machinery for PBCV-1 glycosylation is
encoded primarily, if not totally, by the virus. Furthermore,
glycosylation of the PBCV-1 MCP occurs in the cytoplasm.
The current study addresses two issues related to PBCV-1
glycosylation. First, the structures of the glycans attached to
five PBCV-1 antigenic variant MCPs are described. Second,
using genetic and glycan structure evidence, we identify four
of the putative GT activities involved in the synthesis of the
glycan(s).
Results
Glycan structures from representatives of the antigenic
variants
The structures of the glycans from five different classes
(Class E variants were not included in this study) were deter-
mined by combining chemical (via GC-MS of the appropriate
derivatives) and NMR analyses, using the consolidated ap-
proach developed for PBCV-1 and the other chloroviruses (11,
14 –16). The 1H NMR spectrum of each variant (Fig. 2) differed
from that of WT virus PBCV-1, supporting our hypothesis that
the glycans were different. Accordingly, the features of each
antigenic class will be described in the order of increasing struc-
tural complexity of the glycans. By convention, the monosac-
charide residues identified in each oligosaccharide are labeled
with the same (or a similar) letter used for the analogue unit of
the glycan of the WT virus PBCV-1 (Fig. 1 and Figs. S1–S8 in
the supporting material). Unless mentioned otherwise, we have
focused on the major glycan structure of each of the variants. In
some cases, minor structures made up less than 5–10% of the
total sample.
Class D: Structure of the glycan of the antigenic variant P1L6
This virus is the most difficult to handle in laboratory condi-
tions because it is unstable and tends to degrade during normal
purification procedures. This intrinsic fragility of the viral par-
ticles hindered the obtaining of large amounts of biomass.
Thus, to avoid further losses during chromatographic purifica-
tion, the glycopeptide mixture was studied directly, omitting
this purification step.
Inspection of the 1H NMR spectrum of the P1L6 glycan (Fig.
2 and Fig. S1) showed two anomeric signals at 5.61 and 5.28
ppm along with a set of small signals at 5.0 ppm, whereas the
other regions were crowded with signals from peptides result-
ing from capsid protein digestion.
The structure of the glycan was determined by combining
the chemical data with the analysis of the heteronuclear single
quantum correlation (HSQC) spectrum. GC-MS analysis of the
partially methylated and acetylated alditol derivatives (not
shown) indicated that the sample contained a 2-linked Fuc, a
terminal Gal, a terminal Xyl, and a 3,4-linked Glc. The HSQC
Virus-encoded glycosyltransferases
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spectrum (Fig. S1 and Table S2) had four anomeric resonances,
and the overlap with the spectrum of the PBCV-1 glycan, used
as a reference, permitted the identification of three of the four
residues. As for H (3,4-substituted N-linked -Glc), E (terminal
-Gal), and N (terminal -Xyl), the 13C NMR chemical shifts
were almost identical to that of the reference glycan, with only
minor variations in the 1H NMR chemical shifts. The remaining
carbon resonances were assigned to Fuc A, whose values dif-
fered from those of the reference glycoside (19) due to glycosyl-
ation at C-2. Thus, the N-linked glycan of P1L6 is a tetrasaccha-
ride, significantly truncated compared with that of WT
PBCV-1. It contained all of the units of the chlorovirus N-gly-
cans present in the conserved core region except for the Xyl
attached to Fuc, referred to as the distal Xyl (14).
Class C: Structure of the antigenic variants E11 and E1L3
The identity of the E1L3 and E11 glycans was deduced from
the similarities between the anomeric region of their proton
spectra (Fig. S2A) and by the coincidence of their HSQC spectra
(Figs. S2B and S3). In addition, when compared with P1L6
HSQC (Fig. S1), both E11 and E1L3 had one additional ano-
meric signal at 5.03 ppm.
As for E1L3, comparison of its HSQC spectrum with that
of PBCV-1 glycopeptides permitted the ready identification
of several monosaccharide units (Table S3): the N-linked Glc
H, the proximal Xyl N, and the Gal E. The anomeric proton
at 5.03 ppm was identified by analyzing the other 2D NMR
spectra, including correlation spectroscopy (COSY), total
correlation spectroscopy (TOCSY), and transverse rotating
frame Overhauser effect spectroscopy (T-ROESY). These
data revealed that this resonance arose from a D-Rha unit
linked at O-3 of the Fuc unit A. Unlike the WT glycan, this
D-Rha was not further substituted with the terminal Man G;
therefore, it was labeled F (and not F). Thus, E1L3 and E11
glycans are extended derivatives of P1L6 with the D-Rha unit.
Accordingly, the Fuc residue was substituted at both O-2 and
Table 1
Genetic features of the 20 PBCV-1 antigenic variants
These variants are divided into six classes, depending on their reaction with polyclonal antibodies. Class E is not included in this study and is omitted in this table, because
the members of this group cross-react with the antibodies selective for both Classes A and B, suggesting an intermediate phenotype. All of the antigenic classes except for
C have a mutation in a064r; this gene encodes for a protein of 638 amino acids that includes three domains of 200 amino acids each (Fig. 1). The N-terminal domain 1 is
a GT, domain 2 only matches bacterial proteins of unknown function, and domain 3 has a weak match with methyltransferases. The structure of the N-glycans has been
determined in this work (Fig. 1) for the antigenic variants in boldface type.
Antigenic variant Description
Antigenic Class A: mutation in the
second domain of a064r
(NP_048412.1)
EPA-11 Nonsense mutation (G3 A) at nt position 932 in the gene; truncated protein (307 amino acids)
P9L1 Nonsense mutation (C3 A) at nt position 704 in the gene; truncated protein (234 amino acids)
P9L4 Missense mutation (G3 T) at nt position 1,102 in the gene; amino acid substitution (G368W)
P9L7 Missense mutation (G3 T) at nt position 1,102 in the gene; amino acid substitution (G368W)
P9L10 Nonsense mutation (T3 G) at nt position 669 in the gene; truncated protein (222 amino acids)
P91 Insertion of 27 nt after nt position 952 in the gene; insertion of an additional 9 amino acids
Antigenic Class B: mutation in the
first domain of a064r
(NP_048412.1)
EPA-1 Missense mutation (C3 T) at nt position 236 in the gene; amino acid substitution (S79L)
EPA-2 Frameshift mutation; single nt insertion of A after position 262; truncated protein (88  11 amino acids:
frameshift results in 11 incorrect amino acids added before stop codon is encountered)
P31 Missense mutation (G3 A) at nt position 362 in the gene; amino acid substitution (G121E)
Antigenic Class C: no mutation in
a064r (except E11); mutation in
a075l (NP_48423.1: 280 amino
acids)
E11 Same mutation in a064r as EPA-1 (antigenic class B). Frameshift mutation in a075l; single nucleotide
addition at position 670; truncated protein (223  16 amino acids; frameshift results in 16 incorrect
amino acids added before premature stop codon is encountered)
E1L1 Frameshift mutation; single nt deletion at position 666 in the gene; truncated protein (222 amino acids)
E1L2 Nonsense mutation (G3 A) at nt position 630 in the gene; truncated protein (209 amino acids)
E1L3 Missense mutation (A3 T) in the initiator codon at nt position 1 in the gene; no protein synthesis
E1L4 Nonsense mutation (T3 A) at nt position 659 in the gene; amino acid substitution (I220N)
P41 Frameshift mutation single nt insertion of C after position 194 in the gene; truncated protein (65  14
amino acids: frameshift results in 14 incorrect amino acids added before stop codon is encountered)
Antigenic Class D: a064r fully deleted
P1L2 Large deletion of 27,160 nt between genomic positions 12,320 and 39,480; the deletion includes the 44
nt at the 3 region of gene a014r through and including approximately half of gene a075l
P1L3 Large deletion of 37,450 nt between genomic positions 4,970 and 42,420; the deletion includes gene
a009r through gene a078r (the 5 breakpoint is between genes a007/008l and a009r, whereas the 3
breakpoint is between genes a078r and a079r)
P1L6 Large deletion of 38,642 nt between genomic positions 2,168 and 40,810; the deletion includes the
terminal one-sixth of gene a003r through the middle of gene a077l
P1L10 Large deletion of 32,060 nt between genomic positions 7,700 and 39,760; the deletion includes
approximately 60% of gene a011l through two-thirds of gene a075l
Antigenic Class F: mutation in the
third domain of a064r
(NP_048412.1)
CME6 Frameshift mutation; insertion of 2 nt at position 1,320 in the gene; truncated protein (440  10 amino
acids: frameshift results in 10 incorrect amino acids added before stop codon encountered)
Virus-encoded glycosyltransferases
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O-3 positions, in agreement with the GC-MS linkage analy-
sis of this fraction (Fig. S2C).
Class B: Structure of the glycan of antigenic variants EPA1 and
EPA2
The 1H NMR (Fig. S4A) and HSQC (EPA2 reported as an
example in Fig. S4B) spectra of EPA1 and EPA2 glycopeptides
were almost identical, and both displayed two anomeric signals
at 4.5– 4.4 ppm, the region that in the PBCV-1 WT glycan con-
tains the two -Xyl units M and N.
The units with anomeric signals at 5.63, 5.23, 5.04, 5.01, and
4.42 ppm were readily attributed to the Fuc A, Gal E, D-Rha F,
Glc H, and proximal Xyl N, respectively, by comparison with
PBCV-1 glycan data. Notably, the proton and carbon chemical
shifts of Fuc A (Table S4) indicated that this Fuc was substituted
at all of the positions available, whereas D-Rha F was not
glycosylated.
Hence, NMR analysis focused on the additional anomeric
signal at 4.46 ppm. Studying the connectivities from all of the
2D NMR spectra revealed that this signal belonged to a Xyl unit,
connected to O-4 of A as in the PBCV-1 WT glycan, but not
further substituted. Accordingly, this Xyl was labeled M. Over-
all, the NMR data showed that the structure of the glycans of
the antigenic class B, EPA1 and EPA2, consisted of the con-
served core region characteristic of all of the chlorovirus N-gly-
cans described to date (14 –16) plus the semiconserved ele-
ment, the D-Rha unit F (Fig. 1).
Class A: Structure of the glycans of antigenic variants P91,
P9L1, and P9L10
The glycopeptides from the three variants of Class A shared a
similar pattern of signals in the anomeric region of the 1H NMR
spectra, although some marginal variations of their relative inten-
sities were noted (Fig. S5A). Compared with Class B, the anomeric
region of the 1H NMR spectra of class A contained several addi-
tional signals, and the structural elucidation of these glycopeptides
was performed by the combined analysis of the 2D NMR spectra
(Figs. S5–S7 and Tables S5 and S6) as discussed for the other vari-
ants and detailed in the supporting material.
Figure 1. Glycan structures of WT and selected antigenic mutants of PBCV-1. In the WT, each monosaccharide is denoted with the letter used during the
NMR experiments, and residues inside the dotted box define the conserved core region. The glycosidic linkage of nonstoichiometric substituents is denoted
with a broken line. Glyco1 and glyco2 are the most abundant glycoforms; both have Man. Glyco1 lacks Ara, and the units of the terminal L-Rha disaccharide are
labeled as C and I. Ara is present in glyco2, and the two L-Rha units are labeled B and L. Antigenic classes are labeled with a capital letter (A–D and F), and the
structure of their glycans depends on the kind of mutation found in the genome, which in all cases, except for Classes C and D, occurs in the gene a064r. EPA1
(antigenic Class B) and E11 (antigenic Class C) have identical mutations in domain 1 of a064r, but E11 has an additional mutation in gene a075l. P91 has an
additional glycoform with -L-Rha methylated at O-2; the letters used to label this oligosaccharide are not reported due to crowding, and the structure is
displayed in Fig. S7.
Virus-encoded glycosyltransferases
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Indeed, P9L10 produces a family of four glycopeptides,
named P9L10A–D (Fig. S6), with the distal Xyl M (or M; see
“Discussion” in the supporting material) further elongated with
the -L-Rha unit. These four glycans differed in the nonstoi-
chiometric presence of two residues, Man and Ara, as shown in
Fig. S6.
As for the P9L1 glycopeptides, the HSQC spectrum was
almost superimposable on that of P9L10. Some variations
occurred for the intensities of some signals as deduced by com-
paring their proton spectra (Fig. S5A). In P9L1, the intensities of
E and E were comparable, suggesting that D-Rha was much less
substituted with Man compared with P9L10 glycopeptides.
Densities reporting the Ara (D unit) were not detected, indicat-
ing that this unit was absent or below the detection limit.
Accordingly, P9L1 produced two main glycopeptides, ana-
logues to P9L10A and P9L10B (Fig. S6).
As for the glycopeptides of P91 (Fig. S7 and Table S6),
most of the densities of its HSQC spectrum (Fig. S7, A and B)
overlapped with those of the P9L1 and P9L10 variants. Like
P9L1, the P91 variant lacks the Ara substitution to -L-Rha,
and it produced two oligosaccharides equivalent to P9L10A
and P9L10B, as confirmed by analyzing the homonuclear
spectra (T-ROESY in Fig. S7C and TOCSY in Fig. S7D).
Importantly, these spectra enabled the assignment of densi-
ties that escaped the HSQC detection due to the low amount
of the sample, including C-4 or C-5 of M (the putative posi-
tion of these densities is enclosed in a dotted circle in Fig.
S7B).
The P91 HSQC spectrum contained some additional signals,
including a methyl group at 1H/13C 3.56/62.4 ppm (Fig. S7A)
and an anomeric proton at 1H/13C 4.75/103.4 ppm (Fig. S7B).
NMR analysis of this new residue determined that it was a -L-
Rha, labeled as I, that differed from I and I because it was
methylated at O-2 (Table S6). Methylation at O-2 did not
induce relevant variations in the chemical shift values of all of
the other monosaccharides of the glycan, except for H-4/C-4
values (1H/13C 3.71/80.5 ppm) of the Xyl unit to which it was
attached, named M. For this new oligosaccharide (named P91;
Fig. S7), it was not possible to confirm whether the D-Rha unit F
was further elongated with Man G, although this situation is the
most plausible given the abundance of this residue, similar to
that of Gal or Glc, as visible in the GC-MS profile of the mon-
osaccharide analysis (Fig. S5C). GC-MS analysis also confirmed
the presence of the rhamnose unit methylated at O-2 and
detected a tiny amount of arabinose that escaped the NMR
analysis due to its low abundance.
Class F: Structure of the glycan of antigenic variant CME6
Virus CME6 is the only variant isolated for antigenic class
F. Its proton and HSQC spectra (Fig. 2 and Fig. S8) contained
an additional anomeric signal at 1H/13C 5.04/102.7 ppm (Fig.
S8) when compared with those of the P9L10 variant. Com-
parison of the CME6 HSQC spectrum with that of PBCV-1
readily identified most of the residues, namely A, D–H, M,
and N, for which the positions of all of the proton and carbon
resonances were almost identical. Of note, units E or F
described in class A variants were absent or below the NMR
detection limit, indicating that D-Rha was fully substituted
with Man. Minor differences were found for the chemical
shifts of the residues I and L, the -L-Rha units 2- and 2,3-
linked, respectively.
Analysis focused on the signal C at 1H/13C 5.04/102.7 ppm,
which had a weak H-1/H-2 correlation in the COSY spectrum
(not shown), whereas the TOCSY spectrum read from the H-2
(4.09 ppm) position identified the position of all the other pro-
tons of the unit, with H-6 at 1.26 ppm. Thus, C was a Rha, and
carbon chemical shift values (Table S7) determined that it was
-configured at the anomeric center and not further substi-
tuted. HMBC and T-ROESY spectra showed that it was
attached to O-2 of I, as in the WT virus, with the only difference
that none of its positions were further decorated with a methyl
group (Fig. 1).
As for other minor anomeric signals, it was possible to assign
only that at 1H/13C 5.15/101.8 ppm (Fig. S8), labeled B. It was an
-Rha, which differed from the most intense C because it was
attached to O-2 of L, the -Rha unit with D at O-3.
Collectively, these data indicated that CME6 produces a mix-
ture of two N-glycans (Fig. 1 and Fig. S8), identical to those
described for WT PBCV-1, with the only difference being that
the -L-Rha unit was not methylated.
Figure 2. Anomeric region of the proton spectra of different variants,
each representative of its antigenic class (A–D and F). The proton spec-
trum of the WT virus PBCV-1 is given for comparison (with permission from De
Castro et al. (11)). NMR spectra were recorded at 310 K except for P91 (316 K)
and E1L3 (323 K).
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Predicted PBCV-1– encoded genes involved in the synthesis of
its glycan
Based on the discovery that the structures of the glycans from
the five antigenic classes were truncated versions of the glycan
from the WT PBCV-1 MCP and knowing that PBCV-1 already
had several genes annotated as GTs (12) (Table S1), we could
predict the function of some of them. These predictions were
aided by the fact that the complete genomes of a few represen-
tatives of each of the four groups of chloroviruses mentioned in
the Introduction (NC64A, Osy, SAG, and Pbi viruses) have
been sequenced (7, 15), and the structures of the glycan(s)
attached to their MCPs have been determined (14 –16). The
basic glycan core structure is conserved in all of these viruses
(outlined in Fig. 1). Additional sugar decorations occur on their
respective core N-glycan structures and present a molecular
signature for each chlorovirus. Therefore, knowledge of the gly-
can structures and the presence/absence of genes from the var-
ious groups of chloroviruses contributed to our prediction of
the role for two of the PBCV-1 GTs. The features of each puta-
tive GT are hereafter discussed in light of the structural infor-
mation of the glycans determined in this study.
Class D mutants and the role of A111/114R in the core glycan
assembly/attachment
The four antigenic mutants in Class D (P1L2, P1L3, P1L6,
and P1L10) contain large genomic deletions in similar locations
that range in size from 27.2 to 38.6 kb (genome nucleotide
locations: 12,407–39,576, 5,238 – 42,695, 2,190 – 40,797, and
7,698 –39,722, respectively) or collectively from genes a014r
through a078r (20). All of the chloroviruses (14 –16), as well as
four of the five PBCV-1 antigenic classes, have the conserved
glycan core structure composed of five monosaccharides (one
unit of D-Glc, D-Gal, and L-Fuc and two units of D-Xyl) attached
to the MCP (Fig. 1) plus D-Rha, the semiconserved unit attached
to Fuc.
Class D mutants are the only class with a reduced core glycan
structure (Fig. 1), and this finding supported two conclusions:
(i) the core structure is coded by a gene (or genes) located out-
side of the collective region of the four large deletion mutants,
and (ii) the genes encoding the attachment of the distal D-Xyl,
the fifth unit of the conserved core region, and the D-Rha, the
semiconserved unit of the core glycan, probably lie in the region
between a014r and a078r.
Accordingly, these two observations suggest that the protein
A111/114R (NP_048459.2) is involved in the initiation and/or
attachment of four of the monosaccharides in the conserved
core glycan. Further evidence to support this inference is that
this gene and the corresponding tetrasaccharide are present in
all of the chloroviruses analyzed to date. Because the chlorovi-
rus core glycan is unique in nature, we assume that it must be at
least partially, if not fully, assembled/attached to the MCP by
either a single large viral protein or several smaller viral pro-
teins that are common to all of the chloroviruses. In PBCV-1,
gene a111/114r is the only annotated orthologous GT gene
found outside of the regions of the large deletion mutants
described above that is present in all of the other chloroviruses.
In addition, no MCP glycans smaller than the four-sugar units
have been found in any of the chloroviruses (14 –16) or in the
PBCV-1 antigenic variants (this work).
The a111/114r gene, not including the promoter region,
consists of 2,583 nt, which is longer than any of the other anno-
tated PBCV-1 GT genes. This gene encodes the protein A111/
114R, which consists of 860 amino acids organized into at least
three domains; the second domain has been annotated as a GT
(9).
Because of the size of the a111/114r gene, it is highly likely
that mutations have occurred in the gene over time, but such
mutations are probably lethal because no variant has been iso-
lated. The working model is that a mutation in the a111/114r
gene, and in the orthologous genes from all of the chloroviruses,
would result in the absence of a glycan core attached to the
MCP, leading to the loss of a viable virus. This leads to the
conclusion that the unique four-sugar structure is the minimal
glycan required for chlorovirus survival, although the way it
contributes to the viability of the virus is still unclear. Certainly,
the hydrophilic nature of the glycans would help the virus to
remain soluble, and thus infective, in an aquatic environment.
Furthermore, as noted above, Class D variants are unstable in
the laboratory, suggesting that the glycans may be important
for MCP folding and/or for the correct assemblage of the
capsid.
Thus, all available evidence supports the conclusion that
A111/114R plays a key role in the assemblage of part or all of the
conserved core oligosaccharide.
Class C mutants and the role of A071R
The glycans of the Class C mutants (Fig. 1) differ from those
of Class D because they have a D-Rha attached to L-Fuc; how-
ever, like the Class D mutants, the Class C mutants lack the
distal D-Xyl and its attached sugars. The gene encoding the
enzyme involved in the attachment of D-Rha to L-Fuc is located
somewhere in the region between genes a005r and a077l
because the Class D antigenic mutant P1L6, which lacks the
D-Rha, has no mutations in its genome other than the large
deletion that extends from gene a005r to a077l. Therefore, the
gene that encodes the protein that performs this task must (i) lie
between genes a005r and a077l; (ii) be found in other NC64A
viruses and OsyNE5, all of which have a D-Rha attached to the
L-Fuc; and (iii) must be absent in SAG and Pbi viruses because they
lack a D-Rha in that position. The only PBCV-1 gene that fits all of
these requirements is a071r. The protein encoded by this gene,
A071R (NP_048419.1), is of sufficient size (354 aa) to be a GT,
although it has not been annotated as such. However, A071R does
have a sequence similar to A064R domain 2, which also has not
been annotated as a GT but for which there is strong evidence that
it is a rhamnosyl GT (discussed below).
Class C mutants and the role of A075L
Class C antigenic variants also have mutations that pre-
vent the addition of the distal D-Xyl, which is necessary
before the addition of the two L-Rha units. As noted above in
the discussion of the Class D large deletion mutants, the
protein that attaches the distal D-Xyl to the L-Fuc must be
encoded by a gene that lies between the genes a014r and
a078l. The genetic evidence supports the hypothesis that the
Virus-encoded glycosyltransferases
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protein A075L (NP_048423.1) attaches D-Xyl to L-Fuc. This
protein was previously annotated as an exostosin (Pfam
database code PF03016.8), classified within the GT47 family.
Six Class C antigenic mutants were genomically sequenced
(E1L1, E1L2, E1L3, E1L4, P41, and E11), and all six have
mutations in the a075l gene, but none of them shared muta-
tions in any of the other genes that putatively encode GTs.
The mutations in the gene a075l were of three types: (i)
frameshift mutations that cause premature termination of
the synthesis of the A075L protein; (ii) nonsense mutations
that lead to premature termination of A075L protein synthe-
sis; and (iii) in one case a missense mutation in the initiator
codon that results in a failure to initiate A075L protein syn-
thesis. One of the Class C mutants, E11, is of particular inter-
est. E11 is derived from the Class B antigenic mutant EPA-1,
but the mutation common with EPA-1 became masked when
E11 acquired a second mutation, located in gene a075l,
which prevents the addition of the distal D-Xyl, the feature
that distinguishes the Class C mutants from those in Class B.
Additional evidence that supports the role of A075L comes
from seven other chlorovirus species whose MCP glycan struc-
tures have been determined (14 –16). Even though these seven
chloroviruses infect four different algal hosts, all of them have
the same glycan core structure and the same distal D-Xyl
attached to the L-Fuc, as does the WT PBCV-1. These seven
chloroviruses all encode orthologs of the PBCV-1 A075L
protein.
Class B mutants and the role of A064R domain 1 (A064R-D1)
Class B antigenic variants lack the terminal two L-Rha moi-
eties (Fig. 1) but have the terminal D-Xyl because they all have a
functional a075l gene; however, they have mutations that pre-
vent further elongation of the oligosaccharide chain. Three
Class B antigenic variants have been genomically sequenced
(EPA-1, EPA-2, and P31), and all have mutations in the a064r
gene, which encodes the protein A064R (NP_048412.1). This
protein consists of 638 amino acids that are organized into at
least three functional domains of 200 amino acids each (Fig.
1). More specifically, all three Class B antigenic variants have
mutations in the region of the a064r gene that encodes domain
1 of A064R.
Previous studies annotated this domain as a “fringe class” GT
and hypothesized that the DXD motif coordinated the phos-
phate of the nucleotide sugar, presumably UDP-Glc, and a diva-
lent cation, Mn2 (21, 22). The specificity of this domain could
not be inferred at that time because the structure(s) of the
N-glycans was unknown, preventing any hypothesis about the
nature of the possible acceptor and donor substrates.
Understanding the function of domain 1 was inferred by
comparing the N-glycans of Class B with those of Class A vari-
ants. These two sets of N-glycans (Fig. 1) differ in the presence
of the -L-Rha unit I (or L), supporting the hypothesis that the
first domain of A064R encodes a -L-rhamnosyltransferase that
adds this monosaccharide to O-4 of a Xyl unit M.
As a possible nucleotide donor, we hypothesize that
A064R-D1 uses UDP-L-rhamnose as substrate, whereas most
prokaryotic enzymes recognize the dTDP-bound sugar. This
difference can be explained by the fact that, in contrast to GDP-
L-fucose or GDP-D-Rha that can be produced by virus-derived
enzymes (23), a UDP-L-rhamnose biosynthetic pathway is not
encoded by the PBCV-1 genome. Thus, the nucleotide-acti-
vated L-rhamnose is presumably synthesized by the chlorella
host, using a typical plant UDP-L-rhamnose biosynthetic path-
way (24). This hypothesis is corroborated by both docking stud-
ies (see below) and biochemical evidence that A064R domain 1
has this predicted activity.4
Class A mutants and the role of A064R domain 2
Class A antigenic variants only lack the terminal -L-Rha.
Three variants of this antigenic class have been genomically
sequenced (P91, EPA-11, and P9L1), and all of them lack muta-
tions in domain 1 of a064r, but all three have mutations in
domain 2 of this gene (Fig. 1), which encodes a bacterially
derived protein of unknown function. Furthermore, none of
these three variants has mutations in the gene that encodes
A075L. Thus, these three members of class A are able to add the
terminal D-Xyl and the -L-Rha to the core glycan (Fig. 1). Two
of the three mutants, P9L1 and EPA-11, have nonsense
mutations (point mutations that become stop codons) that
lead to premature termination of translation. The third
mutant, P91, has a 27-nucleotide insertion in the region of
a064r that encodes domain 2. In addition, the a064r gene of
another class A mutant, P9L10, was amplified by PCR and
sequenced. P9L10 acquired a nonsense mutation in a064r
that results in premature termination of A064R near the N
terminus of domain 2; consequently, the functions of both
domain 2 and 3 are lost.
In summary, all of the class A variants encode a functional
domain 1 of A064R but are unable to encode a functional
domain 2. These results are consistent with the glycan structure
results, which support the hypothesis that domain 2 is involved
in the attachment of the second Rha unit (C or B), the one with
an  glycosidic linkage, placed at O-2 of the first L-Rha unit (I or
L). For the reasons mentioned for A064R-D1, our working
hypothesis is that the second domain of A064R accepts UDP-
L-Rha as donor.
Class F mutant and the role of A064R domain 3
The antigenic variant CME6, whose genome has been
sequenced, is the only member of antigenic class F (Table 1).
The CME6 a064r gene has a TC dinucleotide insertion at
genome position 36,276, which leads to premature chain termi-
nation during translation of domain 3, whereas the first two
domains are unaffected. Accordingly, the N-glycans of this var-
iant contain all of the sugars that comprise the WT glycan but
lack the methyl groups at the O-2 and O-3 positions of the
terminal Rha unit C or B (Fig. 1). This finding confirms the role
of the first two domains of A064R; namely the first domain
attaches -L-Rha (I or L) to -Xyl M, and domain 2 attaches the
last Rha unit (C or B) to the -L-Rha.
Whereas PBCV-1 encodes numerous DNA methyltrans-
ferase genes, the only mutated methyltransferase gene in CME6
is in the region of gene a064r that encodes domain 3 (Fig. 1).
The best hit in a BLAST search of the WT amino acid sequence
4 Unpublished observations.
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of domain 3 to the nucleotide database at NCBI was to 2-O-
rhamnosylmethyltransferases. Indeed, when the rhamnosyl-
methyltransferase from Mycobacterium smegmatis (25), was
BLASTED against the PBCV-1 protein database, the only hit
was to domain 3 of A064R (33% identity and 49% positive).
Consequently, when a064r is mutated in the third domain, the
corresponding N-glycan is not methylated at either the O-2 or
O-3 position, suggesting that this methyltransferase can per-
form a double methylation of the monosaccharide. However,
we cannot exclude the possibility that domain 3 attaches only
one methyl group and that a second methyltransferase, yet to be
identified, is required to complete the full decoration of this
Rha.
The mutant P91, a Class A variant, provides additional sup-
port that domain 3 is a rhamnosylmethyltransferase. In the case
of P91, domain 3 of A064R is translated correctly because the
27-nucleotide insertion in the second domain of a064r main-
tains the correct reading frame during its translation. Analysis
of the P91 glycopeptide mixture detected a minor form with
-L-Rha methylated at O-2 (I) (Fig. S7). Thus, domain 3
appears to be functional in P91, but it lacks its natural substrate
because the -L-Rha unit C (or B) is not assembled at the end of
the glycan (see PBCV-1 structure in Fig. 1 and P91 glycan struc-
ture in Fig. S7), but there is a -L-Rha for which it may have a
reduced affinity.
Modeling of UDP-Rha into the catalytic domain 1 of A064R
Based on the evidence collected in this study, A064R-D1 is
predicted to use UDP-L-Rha as the activated donor to synthe-
size the -L-Rha-(1,4)--D-Xyl linkage. In a previous study (22),
this domain was cloned and crystallized, and the authors tested
several nucleotide sugars, but not UDP-L-Rha. The best affinity
was found for UDP-Glc. Therefore, a molecular modeling
approach was used to determine whether UDP-L-Rha is an
acceptable substrate for this GT.
Docking methods are widely used to define or predict the
binding mode of a small ligand to a receptor. Although these
methods are efficient in discriminating between binders and
nonbinders, they are not particularly accurate and typically
cannot discriminate between substrates that differ by less than
1 order of magnitude in affinity (26). This is the case for the
possible Rha/Glc relative selectivity for A064R-D1. Subtle dif-
ferences originate from contributions of hydrogen bonds and
CH/ staking interactions. Thus, a molecular dynamics (MD)
approach was used (27, 28). The structure deposited in the pro-
tein database (PDB accession number 2P72) contains UDP-Glc
as substrate. Therefore, its behavior was compared with that
computed for the UDP-L-Rha analogue.
In the X-ray structure, the donor UDP-Glc is stabilized in the
binding site by several hydrogen bonds and Mn2-oxygen
interactions. Specifically, upon ligand binding, the protein
undergoes a major conformational change, which shifts Phe-13
toward the uracil ring of UDP. Two hydrogen bonds between
the Phe-13 backbone atoms and the uracil ring are established.
These same hydrogen bond interactions are established (Fig. 3,
compare panel A with D and panel B with E) in the model of
A064R-D1 bound to UDP-L-Rha and kept throughout the
entire simulation time (Fig. S9). Similarly, the hydrogen bond
network described for the ribose moiety in the X-ray structure
is also maintained during the whole MD simulation (Fig. 3 (B
and E) and Fig. S9). Specifically, the carbonyl oxygen of Gly-11
interacts with the OH-2 of ribose, whereas the NH of Ser-79 is
a hydrogen bond donor to O-3 of ribose. The hydrogen bond
between the carboxyl side chain of Asp-78 and the OH-3 of
ribose is established only in the last 25 ns of the MD simulation
(Fig. S9).
It has previously been described that His-54 experiences a
significant conformational change upon UDP-Glc binding (Fig.
3C), suggesting a key role for this residue as the required cata-
lytic base (22). Along this line, the MD simulation of A064R-D1
with UDP-Rha clearly identifies a stacking interaction among
the histidine electron cloud and the C-H moiety of the less polar
face of Rha (Fig. 3F). This CH/ interaction is stable in all of the
MD simulations (Fig. S9). These findings are in full agreement
with the previous hypothesis (22) about the role of N in His-54,
which stabilizes the partial positive charge that develops during
the reaction at the C-1 atom. In fact, the C-1–N distance is only
4.5 Å on average (Fig. 3F and Fig. S9). Finally, UDP-L-Rha is kept
in the catalytic site by a polar network involving Arg-57 and
Pro-149, which makes hydrogen bonds with OH-4 of the sugar
ring (Fig. 3F and Fig. S9).
Next, the free energy of binding for both UDP-L-Rha and
UDP-Glc to A064R-D1 was estimated by MM/GBSA methods
(25, 26). Interestingly, the computations predict that the bind-
ing free energy for the A064R-D1/UDP-L-Rha complex is 6
kcal/mol lower than that for the A064R-D1/UDP-Glc analogue
Figure 3. Comparison of the active sites from the X-ray crystal structure
of A064R-D1_WT:UDP-Glc (A–C), a representative frame from MD simu-
lation of A064R-D1_WT:UDP-L-Rha (D–F), and a minimized structure of
the mutant A064R-D1_S79L:UDP-L-Rha (G–I). A, B, D, and E, the binding
mode of UDP is essentially the same in either the UDP-Glc crystal structure or
the UDP-L-Rha MD simulated structure. C and F, as expected, a different inter-
molecular interaction network is observed. For UDP-L-Rha, the His-54 moves
toward the Rha ring, establishing CH/ interactions with the sugar (green
dotted lines). G–I, mutation of the Ser-79 by Leu dramatically alters substrate
binding. Most of the intermolecular interactions are abrogated. Hydrogen
bonds are highlighted with red dotted lines, -stacking (in F) is highlighted
with green dotted lines. UDP-Glc, UDP-L-Rha, and key residues of the enzyme
are shown as blue, red-purple, and green sticks, respectively. Manganese is
represented as a purple sphere.
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(Table 2), in agreement with the prediction of the specificity of
this GT and our preliminary experimental results.4 Among the
key components of the binding free energy, UDP-Glc displayed
the largest electrostatic energy changes upon binding (EELE)
and also showed the largest polar solvation energy (GSol).
Thus, the computational analysis strongly suggests that the
major factor favoring the binding of A064R-D1 for UDP-L-Rha
over UDP-Glc is the lower polar character of Rha with respect
to Glc. These results are also in agreement with the low polarity
of the A064R-D1– binding site defined by Pro-149, Phe-148,
and Tyr-150, which perfectly fit with the methyl substituent of
Rha through hydrophobic interactions. Furthermore, we inves-
tigated why the antigenic variant EPA-1 lacks the terminal
L-Rha moieties, by docking the A064R_S79L mutant with UDP-
Rha substrate. The results of the analysis show that the bulky
side chain of the Leu-79 entails the reorganization of the DXD
motif, with a consequent loss of Mn2 coordination and most
of the essential interactions with the substrate. Specifically,
although the hydrogen bonds between the Phe-13 and the ura-
cil ring are preserved (Fig. 3G), the hydrogen bond network for
the ribose moiety is completely abrogated (Fig. 3H). Even more,
His-54 is now 90° flipped, precluding CH/ interactions (Fig.
3I). These structural data provide an explanation for the
observed truncated oligosaccharide chain in the EPA-1 anti-
genic variant.
Discussion
Unlike the great majority of viruses, the chlorovirus PBCV-1
encodes most, if not all, of the machinery to glycosylate its
MCP. In this study, the truncated glycan structures from a set of
PBCV-1 antigenic variants were determined. These structures
plus genetic evidence led to the identification of four GT activ-
ities encoded by three PBCV-1 genes, a064r, a071r, and a075l,
and enabled us to predict their functions. The a064r gene
encodes a 638-amino acid protein with three domains: domain
1 is a putative -L-rhamnosyltransferase; domain 2 is a previ-
ously unknown GT, here defined as probably being an -L-
rhamnosyltransferase; and domain 3 is a methyltransferase that
decorates one or both positions of the terminal -L-Rha unit.
Therefore, we predict that the A064R protein produces the
disaccharide 2,3-diOMe--L-Rha-(1,2)--L-Rha attached to
O-4 of the distal Xyl unit (Fig. 4). Gene a071r is predicted to
encode a GT that attaches a semiconserved -D-Rha to O-3 of
the L-Fuc located in the N-glycan core region (Fig. 4). Gene
a075r is predicted to encode the -xylosyltransferase that
attaches a D-Xyl unit to O-4 of the same L-Fuc unit used as a
substrate by A071R (Fig. 4). Finally, the putative GT(s) encoded
by the a111/114r gene is predicted to be involved in the synthe-
sis of four of the five residues composing the conserved glycan
core structure (Fig. 4), because it is one of the few annotated GT
encoding genes that is present in all the chloroviruses. How-
ever, it is not known whether A111/114R transfers one or more
of the sugars of the tetrasaccharide described in variant P1L6
(Fig. 1). We cannot exclude the possibility that one or more
other unknown PBCV-1– encoded proteins besides A111/114R
are involved in the assembly/attachment of the core glycan
structure to the MCP. Alternatively, a host-encoded enzyme(s)
could also be involved in the synthesis/attachment of the glycan
core structure.
Virally encoded glycosylation is an emerging concept in
virology, and it is not confined to virus PBCV-1. Other chloro-
viruses possess the genetic tools to accomplish this task, and the
same scenario probably occurs in other taxonomically unre-
lated viruses. Indeed, bovine herpesvirus and myxoma virus
encode a -(1,6)-GlcNAc- and a -(2,3)-sialyltransferase,
respectively (29). In addition, we predict that many of the giant
viruses, characterized by large particle size and very large
genomes (30), will encode at least some, if not all, of the
enzymes needed to glycosylate their glycoproteins.
The list of giant viruses includes all of the known members of
the Mimiviridae and Pandoraviridae families, along with Pitho-
virus and Mollivirus sibericum (30) and many others that are
rapidly being discovered.
The giant viruses mentioned above differ in morphology,
genome size, and physical size, but they share a common trait in
Table 2
Calculated binding free energies (kcal/mol) for UDP-Rha (UDP-Rha) and UDP-Glc (UDP-Glc) to A064R-D1
The binding free energy (Gbind) is decomposed into different energy terms: the gas-phase interaction energy (Egas) between the receptor and the ligand is the sum of
electrostatic (EELE) and van der Waals (EVDW) interaction energies. The solvation free energy (Gsol) is divided into the polar (GGB) and non-polar (GSurf) energy
terms.
Substrate EELE EVDW Egas GSurf GGB GSol Gbind
kcal/mol kcal/mol kcal/mol kcal/mol kcal/mol kcal/mol kcal/mol
UDP-Rha 200.21 26.13 226.35 6.17 152.90 146.73 79.63
UDP-Glc 230.84 24.86 255.71 7.11 188.85 181.74 73.97
Figure 4. PBCV-1 glycan structure with the predicted GTs involved in the
glycosidic bond formation. The CAZY family fold is indicated in parentheses
next to the gene name (unk, unknown function, predicted as GT in this study;
nc, unclassified GT fold). Based on the data available, a111/114r is involved in
the formation of the tetrasaccharide enclosed in the inner gray box. Currently,
it is unknown whether it catalyzes the formation of one or more of the four
glycosidic linkages enclosed. The larger gray box indicates the monosaccha-
ride units of the conserved N-glycan core region that is common to all other
chloroviruses examined to date. D1, D2, and D3, the three domains of protein
A064R. Linkages for which the corresponding GT is not identified yet are the
nonstoichiometric substituents, Man and Ara, which have a question mark
beside them.
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that their genomes have several glycogenes (i.e. genes encoding
enzymes able to manipulate sugar-nucleotides and GTs). Past
work has demonstrated that mimivirus encodes three of the
enzymes needed to synthesize UDP-GlcNAc (31), along with a
functional pathway for UDP-Rha (32) and for UDP-N-Acetyl-
viosamine production (33, 34) and a functional glycogenin par-
alogue (35). For many of the giant viruses, except for the glyco-
genin of mimivirus (35), the activities of the putative glycogenes
are yet to be determined.
If our prediction about giant viruses is correct, investigations
of these organisms will provide the field of glycobiology with
new discoveries and may ultimately answer the central question
about what benefits these viruses have by maintaining their
own glycosylation machinery through evolution.
Finally, interest in the new GTs described in this report goes
beyond the viral world, as they have similarities with prokary-
otic and eukaryotic enzymes, as exemplified by A064R-D1, for
which the best matches are with LgtA, a prokaryotic protein,
and with a bovine -(1,3)-galactosyltransferase (22).
Experimental procedures
Virus growth and glycopeptide isolation from major capsid
proteins
Antigenic variants of PBCV-1 (P9L10, P9L1, P91, EPA-1,
EPA-2, E11, E1L3, P1L6, and CME6) were grown by infection of
4 liters of C. variabilis NC64A cells and purified as described
previously (36) with some modifications as follows. Lysates
were exposed to 1% Triton X-100 before two successive rounds
of gradient centrifugation in 10 – 40% sucrose. The virus was
treated with proteinase K (0.02 mg/ml) between the sucrose
gradients to remove external contaminating proteins. The iso-
lation of their MCPs followed an established protocol (16). Iso-
lated amounts of MCP ranged from 0.2 to 1.5 mg. To isolate the
glycopeptides, the MCP from each variant was dissolved in
water and digested with proteinase K (Sigma catalog no.
P6556). The digestion process was conducted three times over
a time interval of 36 h using proteinase K at 20% by weight of
the starting amount of the MCP. The glycopeptide mixture was
purified via size-exclusion chromatography as reported (11).
Each antigenic variant produced one main glycopeptide frac-
tion, eluting at 50% of the column volume, with the exception
of virus E1L3, which produced two glycoforms. The less abun-
dant form was about 5–10% of the total mixture; its proton
spectrum was similar to that of the WT virus, and it was not
investigated further in this study. For the P1L6 virus variant,
due to the low amount of the virus available, the purification
step was omitted to avoid further losses. This glycopeptide was
analyzed directly via NMR spectroscopy; signals arising from
the nonglycosylated peptides did not hinder the analysis of the
glycan portion.
Glycopeptide chemical analysis
Partially methylated acetylated alditols and fully acetylated
alditols were generated from the purified glycoprotein (0.2
mg) or on the glycopeptides according to published protocols
(37). Analyses of these derivatives were carried out via GC-MS
on an Agilent Technologies Gas Chromatograph 6850A inter-
faced with a selective Mass Detector 5973N equipped with a
SPB-5 capillary column (Supelco, 30 m  0.25-mm inner diam-
eter, flow rate 0.8 ml min1 using helium as the carrier gas).
Electron impact mass spectra were recorded with an ionization
energy of 70 eV and an ionizing current of 0.2 mA. The follow-
ing temperature program was used: 150 °C for 5 min, 3 °C/min
up to 300 °C, 300 °C for 5 min.
NMR acquisition conditions
All NMR experiments were carried out on a Bruker DRX-600
spectrometer equipped with a cryoprobe, calibrated with ace-
tone used as an internal standard (H  2.225 ppm; C  31.45
ppm), and recorded in D2O at 310 K (CME6, E11, EPA1, EPA2,
P9L1, P9L10, and E1L6), at 316 K (P91), or at 323 K (E1L3) to
shift the signal of the residual water peak to minimize its over-
lap with some of the glycopeptide signals. The complete set
of two-dimensional spectra (DQ-COSY, TOCSY, T-ROESY,
gHSQC, and gHMBC) were recorded for all glycopeptides,
except for PIL6, P9L1, and E11, for which the gHSQC experi-
ment was enough to establish the structure of the glycan. The
spectral width was set to 10 ppm, and the frequency carrier was
placed at the residual HOD peak, suppressed by presaturation.
Two-dimensional spectra were measured using standard
Bruker software; for all of the experiments, 512 FIDs of 2,048
complex data points were collected, 32 scans per FID were
acquired for homonuclear spectra, and mixing times of 100 and
300 ms were used for TOCSY and T-ROESY spectra acquisi-
tion, respectively. Heteronuclear 1H-13C spectra were mea-
sured in the 1H detection mode, gHSQC spectrum was
acquired with 30 – 60 scans per FID (depending on the abun-
dance of the sample), the GARP sequence was used for 13C
decoupling during acquisition, and gHMBC scans doubled
those of the gHSQC spectrum.
Bioinformatics
Geneious version 11.0.5 software (38) was used to deepen the
genetic analysis of the variants to identify other genes involved
in glycosylation or to define the nature of the mutation. The
software was used to assemble and map antigenic mutant-se-
quencing reads (total genome) to the PBCV-1 WT reference
genome. The software allowed for quick and easy identification
of genetic variants in the antigenic mutant viruses.
MD simulation of UDP-Rha and UDP-Glc with domain 1 of
A064R
The starting structure for MD simulation of the GT A064R
D1 in complex with the substrate UDP-L-Rha was generated by
replacing the Glc unit of the UDP-Glc with L-Rha in the com-
plex with the enzyme (PDB code 2P72). The structures of the
UDP-Rha and UDP-Glc were relaxed by energy minimization
with a low gradient convergence threshold (0.05) in 1,000 steps
with MM3* force field integrated in the MacroModel program
run under Maestro (release 2016-4) (Schrödinger, LLC, New
York, NY). The nucleotide moieties of the minimized UDP-L-
Rha and UDP-Glc were superimposed on the UDP molecule in
the structure of A064R in complex with UDP (PDB code 2P73).
Partial charges of the ligands were calculated using the Gauss-
ian 09 package with HF/6 –31G(d) basis set. All molecular
parameters were converted using the Antechamber program in
Virus-encoded glycosyltransferases
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the Amber16 package. The resulting structures were used as
starting points for molecular dynamics simulation of 100 ns in
explicit water solvent, using the Amber16 program with the
protein.ff14SB force field parameters for protein and the gen-
eralized amber force field gaff2 for the sugar nucleotide,
whereas the water.tip3p force field was used for water and ions.
The atomic parameters for the Mn2 ion were defined accord-
ing to published data (39). The starting structures were solvated
in a 10-Å octahedral box of explicit TIP3P waters, and counte-
rions were added to maintain electroneutrality. To fill all of the
protein cavities with water molecules, a previous minimization
for only solvent and ions was made. To reach a low-energy
starting structure, the entire system was minimized with a
higher number of cycles, using the accurate steepest descent
algorithm. The system was subjected to two rapid molecular
dynamic simulations (heating and equilibration) before starting
the real dynamic simulation: (i) 20 ps of MD heating the whole
system from 0 to 300 K, using NVT (a fixed number of atoms
(N), a fixed volume (V), and a fixed temperature (T)) ensemble
and a cutoff of 10 Å, followed by (ii) equilibration of the entire
system over 100 ps at 300 K using NPT (a fixed number of atoms
(N), a fixed pressure (P), and a fixed temperature (T)) ensemble
and a cutoff of 10 Å. A relaxation time of 2 ps was used to
equilibrate the entire system in each step. The equilibrated
structure was the starting point for the final MD simulations
at constant temperature (300 K) and pressure (1 atmosphere).
Molecular dynamics simulation without constraints was re-
corded, using an NPT ensemble with periodic boundary condi-
tions, a cutoff of 10 Å, and the particle mesh Ewald method.
Coordinates and energy values were recorded every 10,000
steps (20 ps) for a total simulation time of 100 ns and an ensem-
ble of 5,000 MD frames. A detailed analysis of the MD trajectory
(for example, root mean square deviation evaluation, kinetic
and potential energies, etc.) was accomplished using the cpptraj
module included in the AmberTools16 package, and it is gath-
ered in the supporting material (Fig. S9). The structure of the
GT from antigenic variant EPA-1, GT A064R D1_S79L mutant,
in complex with the substrate UDP-L-Rha was generated by the
mutagenesis tool integrated into the PyMOL program (PyMOL
Molecular Graphics System, version 2.0, Schrödinger, LLC).
The generated structure was minimized using the Amber16
program as described above.
MM/GBSA calculations
Binding free energy analysis was performed by applying
the MM/GBSA calculation. The molecular mechanic energies
combined with the generalized Born and surface area contin-
uum solvation method were applied to the structure of UDP-L-
Rha and UDP-Glc, A064R-D1, and the UDP-L-Rha/A064R-D1
and UDP-Glc/A064R-D1 complexes generated from the MD
simulations, as described above. The receptor/ligand com-
plexes were energetically minimized by the MM/GBSA method
as implemented in the Sander program of the Amber package.
The atomic radii (set default PBRadii mbondi2) were chosen for
all GBSA calculations. For the ensemble-average MM/GBSA
rescoring, an MD trajectory was obtained for both UDP-L-Rha/
A064R-D1 and UDP-Glc/A064R-D1 complexes. Snapshots of
the complex were extracted from the MD trajectory at every 10
ps. Thus, the final binding free energy is an average of the bind-
ing free energies of 10,000 snapshots.
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Class A: structure of the glycans of the antigenic variants P91, P9L1 and P9L10  
The glycopeptides from the three class A variants had a similar pattern of signals in the 
anomeric region of the 1H NMR spectra, although some variations in their relative intensities were 
observed (Fig. S5A). The resonances at ca. 5.2 ppm included two different protons in a ratio 1:2 in 
P9L10 and P91 while 1:1 in P9L1; the resonances at  5.05 ppm included three signals in P9L10 and 
P9L1 and only two in P91. This type of heterogeneity suggested that these viruses produced a mixture 
of glycopeptides with one or more substituents present in non-stoichiometric amounts, as described 
for the Man and Ara units in the N-glycans of the wild-type virus PBCV-1. The most abundant 
sample, P9L10, was studied first and the structural information derived was used to interpret the 
spectra of the glycopeptides from the other two variants. 
Comparison of P9L10 HSQC spectrum with that of PBCV-1 readily identified a set of 
equivalent residues, namely: A, D, E, F, G, N and H (Fig. 1, Fig. S5B); therefore, our analyses 
focused on the remaining signals. In particular, the resonance at 5.03 ppm was analogous to F’ 
described for the antigenic classes B and C; thus, it was an un-substituted D-Rha. In the HMBC 
spectrum, the F’ unit had a correlation with a signal at 1H/13C 4.23/87.4 ppm, identified as position 
three of A’, a Fuc unit substituted at all positions available and with Gal unit E’ at O-2. Analysis of 
the anomeric proton resonance at 4.46 ppm (Fig. S6), diagnostic of the distal Xyl unit, showed a 
correlation with two different equatorial H-5 signals, at 4.34 and 4.25 ppm, suggesting that this signal 
was a combination of two anomeric protons, labelled M and M”. Compared to M, proton and carbon 
chemical shifts of M” were similar except for the equatorial H-5 and C-4 that in M” were at 4.25 and 
79.7 ppm instead of 4.34 and 80.8 ppm, respectively. We assumed that the difference between M and 
M” depended on the non-stoichiometric substitution of D-rhamnose with Man, and that M” was the 
distal xylose unit the glycan devoid of Man residue (structures P9L10B and P9L10C in Fig. S6). The 
region at 4.8-4.7 ppm contained four anomeric signals, all attributed to -L-Rha units (Figs. S5, S6), 
which were labeled as I, I’, L and L’ (Table S5). The anomeric protons of I and I’ were at 4.73 and 
4.79 ppm, respectively (Fig. S6), and both correlated with a H-2/C-2 at 4.06 (or 4.07)/72.0 ppm. 
Analysis of the TOCSY spectrum from each H-2, determined the position of all the other protons of 
the two units. The 1H and 13C values of these two units (Table S5) disclosed that they were not 
glycosylated while the HMBC spectrum indicated that I was linked to O-4 of M while I’ to O-4 of 
M”.  
As for L and L’, H-2/C-2 and H-3/C-3 were found at 4.24 (or 4.23)/69.3 and 3.71/80.0 ppm, 
respectively. These chemical shift values indicated that both units had a substituent at O-3, due to the 
-glycosylation effect, which displaces C-3 to low fields with respect to the reference value (Bock & 
Pedersen, 1983). L and L’ were linked to M and M”, respectively and both had an Ara unit D at O-
S-3 
 
3, but unlike the PBCV-1 glycan, they were not elongated further with an -Rha unit. Indeed, P9L10 
produces a family of four glycopeptides, named P9L10A-D (Fig. S6), differing in the non-
stoichiometric presence of two residues, Man and Ara, as shown in Fig. S6. 
As for the P9L1 glycopeptides, the amount recovered after purification was low but enough to 
record and compare the HSQC spectrum with that of P9L10. Their two spectra were very similar and 
contained the same densities, with some variations occurring in their intensities as deduced by 
comparing their proton spectra (Fig S5). Indeed, in P9L1 the intensities of E and E’ were comparable 
suggesting that D-Rha was much less substituted with Man compared to P9L10 glycopeptides. 
Densities reporting the Ara unit were not detected in the HSQC spectrum, indicating that this unit 
was absent or below the instrumental detection limit. Accordingly, P9L1 produced two main 
glycopeptides, analogues to P9L10A and P9L10B (Fig. S6). 
The same strategy was applied to the glycopeptides of the P91 variant. Most of the densities of 
its HSQC spectrum (Fig. S7A, B) overlapped with those of the P9L1 variant. Thus, the P91 variant 
produced two oligosaccharides equivalent to P9L10A and P9L10B, as confirmed by analyzing the 
homonuclear spectra (T-ROESY in Fig. S7C and TOCSY in Fig. S7D). Importantly, these spectra 
enabled the assignment of densities that escaped the HSQC detection due to the low amount of the 
sample, including C-4 or C-5 of M” (the putative position of these densities is enclosed in a dotted 
circle in Fig. S7B). 
The P91 HSQC spectrum contained some additional signals, a methyl group at 1H/13C 3.56/62.4 
ppm (Fig. S7A) and a new anomeric proton at 1H/13C 4.75/103.4 ppm (Fig. S7B). NMR analysis of 
the new residue determined that it was a -L-Rha, labelled as I”, that differed from I and I’ because 
it was methylated at O-2 (Table S6); methylation at O-2 did not induce relevant variations in the 
chemical shift values of all the other monosaccharides of the glycan, except for H-4/C-4 values of the 
Xyl unit to which it was attached, named M’”, at 1H/13C 3.71/80.5 ppm instead of 3.75/80.8 ppm, as 
in M of P9L10A or at 3.77/79.7 ppm as in M” of P9L10B. For this new oligosaccharide (named P91, 
Fig. S7) it was not possible to confirm if the D-Rha unit F was further elongated with Man G, although 
this situation is the most plausible because elongation with Man seems to be a dominant trait in this 






Table S1.  Features of putative glycosyltransferases of PBCV-1.  
Putative GT Accession no. Size1 Location2 TM3 CAZy family4 
A064R NP_048412 638 Cytoplasm None GTnc5 
A071R6 NP_048419.1 354 Cytoplasm None Unknown 
A075L NP_048423.1 280 Cytoplasm None GT47 
A098R NP_048446.1 568 Plastid 7 GT2 
A111/114R NP_048459.2 860 Cytoplasm None GT2 
A219/222/226R NP_048569.3 677 Plastid 9-10 GT2 
A473L NP_048829.1 517 Plastid 6 GT2 
A546L NP_048902.4 396 Cytoplasm None GTB 
1Number of amino acids 
2Cellular localization determined using WoLF PSORT Prediction: 
https://www.genscript.com/tools/wolf-psort 
3Number of transmembrane helice predicted using TMHMM v.2.0:  
http://www.cbs.dtu.dk/services/TMHMM/ 
4CAZy Carbohydrate Active Enzyme website:  www.cazy.org 
5GTnc = glycosyltransferase family “not classified” 






Table S2. 1H and 13C chemical shifts of glycopeptide from P1L6, the antigenic variant of Class D. Labels 
used reflect those originally used for the glycan of the wild type virus PBCV-1. For structure, refer to figure 
S1. 
 
  1 2 3 4 5 (5eq;5ax) 6;6’ 
A 1H 5.61 3.94 4.16 3.78 4.73 1.20 
2--L-Fuc 13C 98.7 75.2 70.5 73.7 67.6 16.6 
D 1H 5.28 3.84 3.90 4.02 4.05 3.73 x 2 
t--D-Gal 13C 101.3 70.1 70.7 70.5 72.7 62.5 
H 1H 4.97 3.58 3.92 3.75 3.64 3.96;3.89 
3,4-D--Glc 13C 80.8 75.0 77.3 74.7 78.2 60.1 
N 1H 4.42 3.15 3.44 3.49 3.93;3.26 -- 
t--D-Xyl 13C 103.8 75.0 76.9 70.9 66.2 -- 
 
 
Table S3. Proton and carbon chemical shifts obtained for E1L3 or E11 glycopeptides (class C antigenic 
class). For structure, refer to figure S2 or S3. 
 
  1 2 3 4 5 (5eq;5ax) 6;6’ 
A 1H 5.64 4.09 4.24 3.79 4.76 1.23 
2,3--L-Fuc 13C 98.5 71.9 79.6 73.7 67.6 16.2 
E 1H 5.23 3.85 3.90 4.06 4.06 3.75 x 2 
t--D-Gal 13C 100.6 69.7 70.9 70.4 72.4 62.2 
F’ 1H 5.01 4.11 3.87 3.50 3.82 1.32 
t--D-Rha 13C 104.4 71.4 71.6 73.3 70.1 18.0 
H 1H 5.03 3.61 3.96 3.75 3.67 3.96;3.85 
3,4-D--Glc 13C 80.7 75.0 76.7 74.9 78.1 60.7 
N 1H 4.46 3.18 3.48 3.60 3.99;3.30 -- 




Table S4. Proton and carbon chemical shifts obtained for EPA1 or EPA2 glycopeptides (class B antigenic 
class). For structure, refer to figure S4. 
  1 2 3 4 5 (5eq;5ax) 6;6’ 
A 1H 5.63 4.18 4.22 3.86 4.75 1.31 
2,3,4--L-Fuc 13C 98.6 72.0 77.0 82.5 68.5 16.2 
E 1H 5.23 3.82 3.86 4.03 4.03 3.74;3.71 
t--D-Gal 13C 100.2 69.6 71.0 70.4 72.5 62.3 
F’ 1H 5.04 4.04 3.75 3.50 4.10 1.30 
t--D-Rha 13C 104.0 71.5 71.5 73.3 70.1 17.9 
H 1H 5.01 3.58 3.95 3.72 3.66 3.94;3.83 
3,4-D--Glc 13C 80.4 75.0 76.8 74.9 78.1 60.6 
M’ 1H 4.46 3.39 3.45 3.66 4.03;3.23 -- 
t--D-Xyl 13C 105.6 74.9 77.0 70.6 66.1 -- 
N 1H 4.42 3.14 3.45 3.59 4.03;3.27 -- 
t--D-Xyl 13C 104.1 74.9 77.0 71.0 66.1 -- 
S-6 
 
Table S5. Proton and carbon chemical shifts obtained for the four P9L10 glycopeptides from antigenic class 
A (structures reported in Fig. S6). 
  1 2 3 4 5 (5eq;5ax) 6;6’ 
A 1H 5.62 4.18 4.20 3.87 4.76 1.30 
2,3,4--L-Fuc 13C 98.6 72.0 76.3 82.3 68.5 16.3 
A’ 1H 5.64 4.16 4.23 3.87 4.76 1.30 
2,3,4--L-Fuc 13C 98.6 72.0 77.4 82.3 68.5 16.3 
D 1H 5.19 4.19 4.20 3.92 3.79;3.70 -- 
t--L-Araf 13C 100.3 77.6 74.6 83.1 62.9 -- 
E 1H 5.19 3.79 3.84 4.02 4.03 3.71 x 2 
t--D-Gal 13C 100.1 69.7 71.1 70.6 72.3 62.7 
E’ 1H 5.23 3.83 3.85 4.02 4.03 3.71 x 2 
t--D-Gal 13C 100.3 69.7 71.1 70.6 72.7 62.7 
F 1H 5.06 4.19 3.87 3.58 4.11 1.30 
3--D-Rha 13C 103.5 71.4 79.8 72.4 70.5 18.2 
F’ 1H 5.03 4.04 3.75 3.48 4.14 1.28 
t--D-Rha 13C 104.2 71.6 71.7 73.2 70.2 18.2 
G 1H 5.05 4.08 3.87 3.59 3.81 3.91;3.71 
t--D-Man 13C 104.2 71.5 72.1 68.5 75.1 62.9 
H* 1H 4.97 3.58 3.96 3.71 3.65 3.94;3.83 
3,4--D-Glc 13C 80.8 75.2 77.0 75.0 78.2 60.7 
I 1H 4.73 4.07 3.59 3.35 3.43 1.30 
t--L-Rha 13C 102.6 72.0 73.9 73.4 73.2 18.5 
I’ 1H 4.79 4.06 3.59 3.35 3.38 1.30 
t--L-Rha 13C 102.1 72.0 73.9 73.3 73.2 18.5 
L 1H 4.74 4.24 3.71 3.45 3.43 1.32 
3--L-Rha 13C 102.6 69.3 80.0 71.7 73.2 18.6 
L’ 1H 4.80 4.23 3.71 3.45 3.45 1.32 
3--L-Rha 13C 102.1 69.3 80.0 71.7 73.2 18.6 
M 1H 4.46 3.43 3.58 3.75 4.34;3.28 -- 
4--D-Xyl 13C 105.4 74.8 75.7 80.8 65.7 -- 
M” 1H 4.46 3.43 3.58 3.77 4.25;3.28 -- 
4--D-Xyl 13C 105.4 74.8 75.7 79.7 65.4 -- 
N 1H 4.42 3.15 3.45 3.59 4.03;3.28 -- 
t--D-Xyl 13C 104.1 75.0 77.2 71.1 66.2 -- 
* N-linked Glc appeared as a group of two different anomeric signals at 4.97 and 5.02 ppm, probably due to the heterogeneity in the 
peptide portion. Chemical shifts of the most abundant residue, H, are listed in the table; H’ differed from H only for the chemical 





Table S6. Proton and carbon chemical shifts obtained for the glycopeptides of P91 variants (antigenic class 
A). For simplicity, chemical shift values of the two glycans P9L10A and P9L10B are not repeated and listed 
in Table S4, while this table reports the only values of the new units, I” and M’” (structure named as P91 is 
reported in Fig. S7). 1H and 13C chemical shifts of the methyl group are 3.56 and 62.4 ppm, respectively. For 
structure, refer to figure S7. 
  1 2 3 4 5 (5eq;5ax) 6 
I” 1H 4.75 3.78 3.59 3.27 3.40 1.30 
t-2OMe--L-Rha 13C 103.4 81.7 73.9 73.6 73.2 18.5 
M”’ 1H 4.46 3.43 3.58 3.71 4.34;3.28 -- 








Table S7. Proton and carbon chemical shifts obtained for the two CME6 glycopeptides (structures reported 
in Fig. S8).  
 
  1 2 3 4 5 (5eq;5ax) 6;6’ 
A 1H 5.62 4.17 4.21 3.88 4.74 1.30 
2,3,4--L-Fuc 13C 98.6 72.0 76.2 82.0 68.5 16.3 
B 1H 5.15 4.05 3.86 3.43 4.10 1.26 
t--L-Rha 13C 101.8 71.4 71.3 73.4 4.10 17.8 
C 1H 5.04 4.09 3.86 3.43 4.10 1.26 
t--L-Rha 13C 102.7 72.3 71.3 73.4 69.9 17.8 
D 1H 5.19 4.20 4.20 3.91 3.78;3.71 -- 
t--L-Araf 13C 100.1 77.4 74.1 83.0 62.8 -- 
E 1H 5.19 3.78 3.83 4.00 4.02 3.71 x 2 
t--D-Gal 13C 100.1 69.7 71.2 70.6 72.6 62.6 
F 1H 5.05 4.18 3.86 3.56 4.12 1.30 
3--D-Rha 13C 103.6 71.4 80.0 72.3 70.5 18.2 
G 1H 5.04 4.08 3.86 3.60 3.81 3.91;3.71 
t--D-Man 13C 104.2 71.5 72.1 68.5 75.1 62.9 
H 1H 4.96 3.57 3.95 3.70 3.65 3.93;3.83 
3,4--D-Glc 13C 80.8 75.1 77.0 74.9 78.2 60.7 
I 1H 4.78 4.14 3.70 3.38 3.47 1.30 
2--L-Rha 13C 102.6 78.1 74.6 73.4 73.6 18.5 
L 1H 4.77 4.31 3.74 3.47 3.49 1.32 
2,3--L-Rha 13C 102.6 74.4 80.4 72.4 73.5 18.6 
M 1H 4.44 3.43 3.55 3.74 4.33;3.25 -- 
4--D-Xyl 13C 105.3 75.0 75.9 81.0 65.8 -- 
N 1H 4.41 3.14 3.44 3.59 4.03;3.27 -- 












Fig. S1. Expansion of HSQC spectrum measured at 310 K for P1L6 glycopeptide (antigenic class D). Densities 








Fig. S2. Collection of experimental data acquired for class C variants. A) Comparison of the anomeric region 
of the proton spectra of E1L3 and E11 variants. B) Expansion of HSQC spectrum measured at 310 K for E1L3 
glycopeptide. Densities are labeled with a letter in analogy with that used for PBCV-1 glycans (Fig. 1). C) GC-








Fig. S3. Expansion of HSQC spectrum measured at 310 K for E11 glycopeptide (antigenic class C). Densities 







Fig. S4. Collection of experimental data acquired for class B. A) Comparison of the anomeric region of the 
proton spectra of EPA1 and EPA2 variants. B) Expansion of HSQC spectrum measured at 310 K for EPA2 










Fig. S5. Collection of experimental data acquired for class A. A) Comparison of the anomeric region of the 
proton spectra of P9L10, P9L1, and P91 variants. B) Expansion of HSQC spectrum measured at 310 K for 
P9L10 glycopeptide, equivalent to that of P9L1, which is therefore omitted. Densities are labeled with a letter 
in analogy with that used for PBCV-1 glycans (Fig. 1). C) GC-MS chromatograms of the monosaccharide 
composition as acetylated alditols of P91. Chemical analysis of the other two antigenic variants gave the same 









Fig. S6. Expansion of TOCSY (black) and COSY (cyan/red) spectra detailing the anomeric region of P9L10 
glycopeptide mixture. P9L10 produces a mixture of four different glycopeptides, sketched on the top of the 
figure, and that differ for the nonstoichiometric presence of Man G and Ara D, as occurs in PBCV-1 N-glycans. 
This heterogeneity in substitution induces the splitting of many signals, as for the -Rha unit for which four 
different anomeric signals exist (I, I’, L and L’). Notably, for -Rha, the H-1/H-2 correlation is too weak to 
be detected in the COSY spectrum, while it is visible in the TOCSY, and two vertical dotted gray lines are 
added to indicate that the densities I1,2 and L1,2 (or I’1,2 and L’1,2) do not align. P9L1 produces a mixture of 








Fig. S7. Collection of NMR data acquired for class A variant P91. A,B) expansions of HSQC spectrum 
detailing the hydroxymethyl and carbinolic regions, respectively. Of note, the oligosaccharide P91 produces 
only small amounts of P9L10B glycan therefore some of the correlations are missing, as occurs for H-4/C-4 
M’’ and H-5/C-5 of M’’ densities, whose putative position is indicated with a dotted circle. C) T-ROESY 
spectrum region detailing the correlations of the -Rha units, with that connecting H-1 of I’ pointing to H-4 of 









Fig. S8. Expansion of HSQC spectrum measured at 310 K for CME6 glycopeptide (antigenic class F). 








Fig. S9. Distance evolution among the atoms involved in intermolecular interactions of A064R-D1: UDP-Rha 
as function of simulation time. 
 
 
